𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs. heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial

✍ Scribed by A.M. Lincoff; N.S. Kleiman; D.J. Kereiakes

Book ID
113414507
Publisher
Elsevier Science
Year
2004
Tongue
English
Weight
35 KB
Volume
13
Category
Article
ISSN
1062-1458

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Provisional glycoprotein IIb/IIIa blocka
Provisional glycoprotein IIb/IIIa blockade in a randomized investigation of bivalirudin versus heparin plus planned glycoprotein IIb/IIIa inhibition during percutaneous coronary intervention: Predictors and outcome in the Randomized Evaluation in Percutaneous coronary intervention Linking Angiomax to Reduced Clinical Events (REPLACE)–2 trial
✍ J. Emilio Exaire; Samuel M. Butman; Ramin Ebrahimi; Neal S. Kleiman; Robert A. H πŸ“‚ Article πŸ“… 2006 πŸ› Elsevier Science 🌐 English βš– 179 KB
Randomized evaluation of the efficacy of
Randomized evaluation of the efficacy of enoxaparin versus unfractionated heparin in high-risk patients with non–ST-segment elevation acute coronary syndromes receiving the glycoprotein IIb/IIIa inhibitor eptifibatide. Long-term results of the Integrilin and Enoxaparin Randomized Assessment of Acute Coronary Syndrome Treatment (INTERACT) trial
✍ David H. Fitchett; Anatoly Langer; Paul W. Armstrong; Mary Tan; Aurora Mendelsoh πŸ“‚ Article πŸ“… 2006 πŸ› Elsevier Science 🌐 English βš– 142 KB